G Dijkman
- Naam
- Drs. G. Dijkman
- Telefoon
- +31 71 526 8030
- g.dijkman@lumc.nl
- Faculteit Geneeskunde
- Divisie 3
- Oogheelkunde
- Sirks, M.J.; Feenstra, H.M.A.; Vries, F.R. de; Dijkman, G.; Boon, C.J.F. & Dijk, E.H.C. van (2022), Argon laser photocoagulation in polypoidal choroidal vasculopathy, Clinical & Experimental Ophthalmology.
- Feenstra, H.M.A.; Hahn, L.C.; Rijssen, T.J. van; Tsonaka, R.; Breukink, M.B.; Keunen, J.E.E.; Peters, P.J.H.; Dijkman, G.; Souied, E.H.; MacLaren, R.E.; Querques, G.; Downes, S.M.; Fauser, S.; Hoyng, C.B.; Dijk, E.H.C. van & Boon, C.J.F. (2022), Efficacy of half-dose photodynamic therapy versus high-density subthreshold micropulse laser for treating pigment epithelial detachments in chronic central serous chorioretinopathy, RETINA: The Journal of Retinal and Vitreous Diseases 42(4): 721-729.
- Boer, I. de; Steenmeijer, S.R.; Pelzer, N.; Al-Nofal, M.; Dijkman, G.; Notting, I.C. & Terwindt, G.M. (2022), Spectral Domain Optical Coherence Tomography in Retinal Vasculopathy With Cerebral Leukoencephalopathy and Systemic Manifestations: A Monogenic Small Vessel Disease, Journal of Neuro-Ophthalmology 42(1): E130-E136.
- Rijssen, T.J. van; Dijk, E.H.C. van; Scholz, P.; Breukink, M.B.; Dijkman, G.; Peters, P.J.H.; Tsonaka, R.; Keunen, J.E.E.; MacLaren, R.E.; Hoyng, C.B.; Downes, S.M.; Fauser, S. & Boon, C.J.F. (2021), Long-term follow-up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser, Acta Ophthalmologica 99(7).
- Dijk, E.H.C. van; Mohabati, D.; Veselinovic, S.; Chung, W.H.; Dijkman, G. & Boon, C.J.F. (2020), The spectrum of polypoidal choroidal vasculopathy in Caucasians, Graefe's Archive for Clinical and Experimental Ophthalmology 259.
- Rijssen, T.J. van; Dijk, E.H.C. van; Scholz, P.; Breukink, M.B.; Dijkman, G.; Peters, P.J.H.; Tsonaka, R.; MacLaren, R.E.; Downes, S.M.; Fauser, S.; Boon, C.J.F. & Hoyng, C.B. (2020), Crossover to photodynamic therapy or micropulse laser after failure of primary treatment of chronic central serous chorioretinopathy, American Journal of Ophthalmology 216: 80-89.
- Haalen, F.M. van; vanDijk, E.H.C.; Savas, M.; Brinks, J.; Dekkers, O.M.; Dijkman, G.; vanRossum, E.F.C.; Biermasz, N.R.; Boon, C.J.F. & Pereira, A.M. (2020), Hair cortisol concentrations in chronic central serous chorioretinopathy, Acta Ophthalmologica 98(4): 390-395.
- Haalen, F.M. van; vanDijk, E.H.C.; Savas, M.; Brinks, J.; Dekkers, O.M.; Dijkman, G.; vanRossum, E.F.C.; Biermasz, N.R.; Boon, C.J.F. & Pereira, A.M. (2020), Hair cortisol concentrations in chronic central serous chorioretinopathy , Acta Ophthalmologica 98(4).
- Haalen, F.M. van; Dijk, E.H.C. van; Andela, C.D.; Dijkman, G.; Biermasz, N.R.; Pereira, A.M. & Boon, C.J.F. (2019), Maladaptive personality traits, psychological morbidity and coping strategies in chronic central serous chorioretinopathy, Acta Ophthalmologica 97(4): E572-E579.
- Dijk, E.H.C. van; Fauser, S.; Breukink, M.B.; Blanco-Garavito, R.; Groenewoud, J.M.M.; Keunen, J.E.E.; Peters, P.J.H.; Dijkman, G.; Souied, E.H.; MacLaren, R.E.; Querques, G.; Downes, S.M.; Hoyng, C.B. & Boon, C.J.F. (2019), Re: van Dijk et al.: Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial (Ophthalmology. 2018;125:1547-1555) Reply, Ophthalmology: Journal of The American Academy of Ophthalmology 126(4): E30-E31.
- Dijk, E.H.C. van; Schellevis, R.L.; Breukink, M.B.; Mohabati, D.; Dijkman, G.; Keunen, J.E.E.; Yzer, S.; Hollander, A.I. den; Hoyng, C.B.; Jong, E.K. de & Boon, C.J.F. (2019), FAMILIAL CENTRAL SEROUS CHORIORETINOPATHY, RETINA 39(2): 398-407.
- Dijk, E.H.C. van; Fauser, S.; Breukink, M.B.; Blanco-Garavito, R.; Keunen, J.E.E.; Groenewoud, J.M.M.; Peters, P.J.H.; Dijkman, G.; Souied, E.H.; MacLaren, R.E.; Querques, G.; Downes, S.M.; Hoyng, C.B. & Boon, C.J.F. (2019), Re: van Dijk et al: Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: The PLACE trial Reply, Ophthalmology: Journal of The American Academy of Ophthalmology 126(1): E11-E11.
- Mohabati, D.; Dijk, E.H.C. van; Rijssen, T.J. van; Jong, E.K. de; Breukink, M.B.; Martinez-Ciriano, J.P.; Dijkman, G.; Hoyng, C.B.; Fauser, S.; Yzer, S. & Boon, C.I.F. (2018), Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy, Clinical Ophthalmology 12: 2167-2176.
- Dijk, E.H.C. van; Fauser, S.; Breukink, M.B.; Blanco-Garavito, R.; Groenewoud, J.M.M.; Keunen, J.E.E.; Peters, P.J.H.; Dijkman, G.; Souied, E.H.; MacLaren, R.E.; Querques, G.; Downes, S.M.; Hoyng, C.B. & Boon, C.J.F. (2018), Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy The PLACE Trial, Ophthalmology: Journal of The American Academy of Ophthalmology 125(10): 1547-1555.
- Haalen, F.M. van; Dijk, E.H.C. van; Andela, C.D.; Dijkman, G.; Biermasz, N.R.; Pereira, A.M. & Boon, C.J.F. (2018), Maladaptive personality traits, psychological morbidity and coping strategies in chronic central serous chorioretinopathy., Acta Opthalmologica.
- Rijssen, T.J. van; Dijk, E.H.C. van; Dijkman, G. & Boon, C.J.F. (2018), Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy, Graefe's Archive for Clinical and Experimental Ophthalmology 256(8): 1395-1402.
- Rijssen, T.J. van; Mohabati, D.; Dijkman, G.; Theelen, T.; Jong, E.K. de; Dijk, E.H.C. van & Boon, C.J.F. (2018), Correlation between redefined optical coherence tomography parameters and best-corrected visual acuity in non-resolving central serous chorioretinopathy treated with half-dose photodynamic therapy, PLoS ONE 13(8).
- Holz, F.G.; Sadda, S.R.; Busbee, B.; Chew, E.Y.; Mitchell, P.; Tufail, A.; Brittain, C.; Ferrara, D.; Gray, S.; Honigberg, L.; Martin, J.; Tong, B.; Ehrlich, J.S.; Bressler, N.M. & Chroma Spectri Study Investigators (2018), Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degeneration Chroma and Spectri Phase 3 Randomized Clinical Trials, JAMA Ophthalmology 136(6): 666-677.
- Buitendijk, G.H.S.; Schauwvlieghe, A.S.M.E.; Vingerling, J.R.; Schlingemann, R.O.; Klaver, C.C.W. & Comparing Bevacizumab Ranibizumab (2018), Antiplatelet and Anticoagulant Drugs Do Not Affect Visual Outcome in Neovascular Age-Related Macular Degeneration in the BRAMD Trial, American Journal of Ophthalmology 187: 130-137.
- Haalen, F.M. van; Dijk, E.H.C. van; Dekkers, O.M.; Bizino, M.B.; Dijkman, G.; Biermasz, N.R.; Boon, C.J.F. & Pereira, A.M. (2018), Cushing's Syndrome and Hypothalamic-Pituitary-Adrenal Axis Hyperactivity in Chronic Central Serous Chorioretinopathy, Frontiers in Endocrinology 9.
- Haalen, F.M. van; Dijk, E.H.C. van; Dekkers, O.M.; Bizino, M.B.; Dijkman, G.; Biermasz, N.R.; Boon, C.J.F. & Pereira, A.M. (2018), Cushing's Syndrome and Hypothalamic-Pituitary-Adrenal Axis Hyperactivity in Chronic Central Serous Chorioretinopathy, Frontiers in Endocrinology.
- Chung, W.H.; Dijk, E.H.C. van; Mohabati, D.; Dijkman, G.; Yzer, S.; Jong, E.K. de; Fauser, S.; Schlingemann, R.O.; Hoyng, C.B. & Boon, C.J.F. (2017), Neovascular age-related macular degeneration without drusen in the fellow eye: clinical spectrum and therapeutic outcome, Clinical Ophthalmology 11: 63-70.
- Dijk, E.H.C. van; Dijkman, G. & Boon, C.J.F. (2017), Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea, Graefe's Archive for Clinical and Experimental Ophthalmology 255(10): 2029-2035.
- Schauwvlieghe, A.M.E.; Buitendijk, G.H.S.; Dijkman, G.; Hoyng, C.; Hooymans, J.M.; Verbraak, F.D.; Vingerling, J.R.; Claver, C.C. & Schlingemann, R.O. (2017), Antiplatelet and anticoagulant drugs do not affect visual acuity in the comparing bevacizumab to ranibizumab in age-related macular degeneration (BRAMD) trial, Acta Ophthalmologica 95: 22-23.
- Mohabati, D.; Dijk, E.H.C. van; Rijssen, T.J. van; Jong, E.K. de; Breukink, M.B.; Martinez-Ciriano, J.P.; Dijkman, G.; Hoyng, C.B.; Fauser, S.; Yzer, S. & Boon, C.J.F. (2017), Severe phenotypes of chronic central serous chorioretinopathy: clinical characteristics and response to photodynamic therapy, Acta Ophthalmologica 95: 21-21.
- Stam, A.H.; Kothari, P.H.; Shaikh, A.; Gschwendter, A.; Jen, J.C.; Hodgkinson, S.; Hardy, T.A.; Hayes, M.; Kempster, P.A.; Kotschet, K.E.; Bajema, I.M.; Duinen, S.G. van; Maat-Schieman, M.L.C.; Jong, P.T.V.M. de; Smet, M.D. de; Wolff-Rouendaal, D. de; Dijkman, G.; Pelzer, N.; Kolar, G.R.; Schmidt, R.E.; Lacey, J.; Joseph, D.; Fintak, D.R.; Grand, M.G.; Brunt, E.M.; Liapis, H.; Hajj-Ali, R.A.; Kruit, M.C.; Buchem, M.A. van; Dichgans, M.; Frants, R.R.; Maagdenberg, A.M.J.M. van den; Haan, J.; Baloh, R.W.; Atkinson, J.P.; Terwindt, G.M. & Ferrari, M.D. (2016), Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations, Brain 139: 2909-2922.
- Dijk, E.H.C. van; Dijkman, G.; Biermasz, N.R.; Haalen, F.M. van; Pereira, A.M. & Boon, C.J.F. (2016), Chronic central serous chorioretinopathy as a presenting symptom of Cushing syndrome, European Journal of Ophthalmology 26(5): 442-448.
- Breukink, M.B.; Mohabati, D.; Dijk, E.H.C. van; Hollander, A.I. den; Jong, E.K. de; Dijkman, G.; Keunen, J.E.E.; Hoyng, C.B. & Boon, C.J.F. (2016), Efficacy of photodynamic therapy in steroid-associated chronic central serous chorioretinopathy: a case-control study, Acta Ophthalmologica 94(6): 565-572.
- Tadayoni, R.; Waldstein, S.M.; Boscia, F.; Gerding, H.; Pearce, I.; Priglinger, S.; Wenzel, A.; Barnes, E.; Gekkieva, M.; Pilz, S.; Mones, J. & BRIGHTER Study Grp (2016), Individualized Stabilization Criteria-Driven Ranibizumab versus Laser in Branch Retinal Vein Occlusion Six-Month Results of BRIGHTER, Ophthalmology: Journal of The American Academy of Ophthalmology 123(6): 1332-1344.
- Larsen, M.; Waldstein, S.M.; Boscia, F.; Gerding, H.; Mones, J.; Tadayoni, R.; Priglinger, S.; Wenzel, A.; Barnes, E.; Pilz, S.; Stubbings, W.; Pearce, I. & CRYSTAL Study Grp (2016), Individualized Ranibizumab Regimen Driven by Stabilization Criteria for Central Retinal Vein Occlusion, Ophthalmology: Journal of The American Academy of Ophthalmology 123(5): 1101-1111.
- Schauwvlieghe, A.M.E.; Dijkman, G.; Hooymans, J.M.; Verbraak, F.D.; Hoyng, C.B.; Dijkgraaf, M.G.W.; Peto, T.; Vingerling, J.R. & Schlingemann, R.O. (2016), Comparing the Effectiveness of Bevacizumab to Ranibizumab in Patients with Exudative Age-Related Macular Degeneration. The BRAMD Study, PLoS ONE 11(5).
- Dijk, E.H.C. van; Dijkman, G.; Biermasz, N.R.; Haalen, F.M. van; Pereira, A.M. & Boon, C.J.F. (2016), Chronic central serous chorioretinopathy as a presenting symptom of Cushing syndrome, European Journal of Ophthalmology.
- Bronkhorst, I.H.G.; Marinkovic, M.; Dijkman, G. & Boon, C.J.F. (2015), Untitled, RETINA 35(8): e52-e54.
- Schauwvlieghe, A.M.E.; Dijkman, G.; Hooymans, J.M.; Verbraak, F.D.; Hoyng, C.B.; Dijkgraaf, M.G.W.; Leeuwen, R. van; Vingerling, J.R.; Moll, A.C. & Schlingemann, R.O. (2015), Comparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular Edema: a randomized clinical trial (the BRDME study), BMC Ophthalmology 15.
- Dijk, E. van; Dijkman, G.; Biermasz, N.R.; Pereira, A.M. & Boon, C.J.F. (2015), Chronic central serous chorioretinopathy leading to the diagnosis of Cushing's syndrome, Investigative Ophthalmology & Visual Science 56(7).
- Mohabati, D.; Dijk, E.H.C. van; Breukink, M.; Hoyng, C.C.B.; Marinkovic, M.; Dijkman, G. & Boon, C.J.F. (2015), Influence of corticosteroid use on clinical characteristics and therapeutic outcome in chronic central serous chorioretinopathy, Investigative Ophthalmology & Visual Science 56(7).
- Kooij, S.M. van der; Buchem, M.A. van; Overbeek, O.M.; Dijkman, G. & Huizinga, T.W.J. (2015), Susac syndrome: a report of four cases and a review of the literature, Netherlands Journal of Medicine 73(1): 10-16.
- Geus, S.J.R. de; Jager, M.J.; Luyten, G.P.M. & Dijkman, G. (2013), Shifting exudative age-related macular degeneration patients to ranibizumab after insufficient response to bevacizumab, Acta Ophthalmologica 91(5): E411-E413.
- Heier, J.S. (2013), Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration (vol 119, pg 2537, 2012), Ophthalmology: Journal of The American Academy of Ophthalmology 120(1): 209-210.
- Heier, J.S.; Campochiaro, P.A.; Yau, L.D.; Li, Z.R.; Saroj, N.; Rubio, R.G. & Lai, P. (2012), Ranibizumab for Macular Edema Due to Retinal Vein Occlusions Long-term Follow-up in the HORIZON Trial, Ophthalmology: Journal of The American Academy of Ophthalmology 119(4): 802-809.